First Trust Advisors’s Mesa Laboratories MLAB Stock Holding History

First Trust Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,500	Closed	-$775K	–	2509
2022 Q3	$775K	Buy	5,500 +235	+4%	+$42.9K	﹤0.01%	2080
2022 Q2	$1.07M	Buy	+5,265	New	+$1.15M	﹤0.01%	1958
2021 Q4	–	Sell	-2,043	Closed	-$618K	–	2565
2021 Q3	$618K	Buy	+2,043	New	+$581K	﹤0.01%	2217
2021 Q2	–	Sell	-5,623	Closed	-$1.37M	–	2522
2021 Q1	$1.37M	Buy	5,623 +3,337	+146%	+$918K	﹤0.01%	1871
2020 Q4	$655K	Buy	+2,286	New	+$629K	﹤0.01%	2044
2020 Q3	–	Sell	-3,935	Closed	-$853K	–	2418
2020 Q2	$853K	Buy	+3,935	New	+$907K	﹤0.01%	1815
2020 Q1	–	Sell	-5,646	Closed	-$1.41M	–	2404
2019 Q4	$1.41M	Buy	+5,646	New	+$1.32M	﹤0.01%	1726
2019 Q3	–	Sell	-2,205	Closed	-$539K	–	2436
2019 Q2	$539K	Sell	2,205 -253	-10%	-$58.9K	﹤0.01%	2085
2019 Q1	$567K	Buy	+2,458	New	+$556K	﹤0.01%	2086

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

First Trust Advisors's MLAB Position: Q4 2022 in Review

First Trust Advisors sold out of Mesa Laboratories (MLAB) in Q4 2022, closing a stake of 5,500 shares — an estimated $775K sold.

First Trust Advisors first reported a position in MLAB in Q1 2019 and held it in 9 quarters. The position peaked at $1.41M in Q4 2019. 160 funds tracked by Wall St. Rank hold MLAB as of Q4 2022.

First Trust Advisors reported no remaining Mesa Laboratories position as of Q4 2022 after selling out during the quarter.
First Trust Advisors sold 5,500 Mesa Laboratories shares in Q4 2022, an estimated $775K.
First Trust Advisors first reported a position in Mesa Laboratories in Q1 2019 and held it in 9 quarters.
First Trust Advisors's Mesa Laboratories position peaked at $1.41M in Q4 2019.
160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2022.

Based on First Trust Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.